Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
Brief
"On 27 February 2025, the Ministry of Health and Welfare held the 2nd Advanced Regeneration Medical and Advanced Bio Pharmaceutical Review Committee. The committee reviewed clinical research plans submitted by regeneration medical institutions, including one on using patient-derived salivary gland stem cells (ATORM-S) to treat xerostomia in head and neck cancer patients, which was deemed unsuitable for approval, with the option for re-examination."
Highlights content goes here...
Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
